Brincidofovir for Prevention of Cytomegalovirus (CMV) after Allogeneic Hematopoietic Cell Transplantation (HCT) in CMV-Seropositive Patients: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Trial.

Subjects

Subjects :

*CYTOMEGALOVIRUS disease prevention
*HEMATOPOIETIC stem cell transplantation
*HOMOGRAFTS
*VIRAL replication
*VIRUS reactivation
*RANDOMIZED controlled trials

Details

Language :

English

ISSN :

10838791

Volume :

22

Database :

Academic Search Index

Journal :

Biology of Blood & Marrow Transplantation

Publication Type :

Academic Journal

Accession number :

112390276

Full Text :

https://doi.org/10.1016/j.bbmt.2016.01.009